University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

4-week Mindfulness Program for Adults With Chronic Pain

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Behavioral: Mindfulness Training For Chronic Pain

First Posted Date: 2018-04-12

Last Posted Date: 2019-09-09

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 23

Registration Number: NCT03495856

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Patient and Family Partners in Heart Failure Care: Pilot Test of a Pre-visit Question Prompt List to Enhance Engagement During Medical Visits

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Behavioral: Question/Topic Prompt List

First Posted Date: 2018-04-09

Last Posted Date: 2024-08-22

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 53

Registration Number: NCT03491800

Locations: 🇺🇸
UNC School of Medicine, Chapel Hill, North Carolina, United States

Neurobehavioral Plasticity to Regular Sugar-Sweetened Beverage Intake: An fMRI Experiment

Not Applicable

Completed

Conditions: Obesity
Weight Gain

Interventions: Dietary Supplement: Strawberry Kiwi &Lemonade Flavored Beverage with added sugar
Dietary Supplement: Black Cherry and Orange Flavored Beverage with added sugar
Dietary Supplement: Strawberry Kiwi & Lemonade Flavored Beverage no added sugar
Dietary Supplement: Black Cherry and Orange Flavored Beverage no added sugar
Other: Water

First Posted Date: 2018-04-06

Last Posted Date: 2023-04-06

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 160

Registration Number: NCT03490734

Locations: 🇺🇸
Mcgavran-Greenberg Hall, Chapel Hill, North Carolina, United States

Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence

Phase 2

Withdrawn

Conditions: Fecal Incontinence
Diarrhea
Urge Incontinence
Accidental Bowel Leakage
Anal Incontinence

Interventions: Drug: Eluxadoline 100 mg
Other: Placebo

First Posted Date: 2018-04-05

Last Posted Date: 2019-07-25

Lead Sponsor: University of North Carolina, Chapel Hill

Registration Number: NCT03489265

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

Phase 2

Recruiting

Conditions: Cystic Fibrosis

Interventions: Drug: Trimethoprim Sulfamethoxazole (TMP/SMX)
Drug: Minocycline
Drug: Mupirocin
Drug: Chlorhexidine Gluconate
Behavioral: Environmental Decontamination

First Posted Date: 2018-04-05

Last Posted Date: 2024-04-09

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 42

Registration Number: NCT03489629

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, United States
🇺🇸
University of Washington Medical Center and Seattle Children's, Seattle, Washington, United States

and more 6 locations

19F MRI to Evaluate Regional Ventilation in Healthy Subjects and Subjects With Cystic Fibrosis

Early Phase 1

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: PFP

First Posted Date: 2018-04-05

Last Posted Date: 2019-10-04

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 42

Registration Number: NCT03489590

Locations: 🇺🇸
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Using the LENA System in Early Intervention - b

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Language ENhancement Assessment/intervention system

First Posted Date: 2018-03-29

Last Posted Date: 2019-12-19

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 10

Registration Number: NCT03480841

Locations: 🇺🇸
Durham Children's Developmental Services Agency, Durham, North Carolina, United States

Comparison of 129Xe MRI With 19F MRI in CF Lung Disease

Early Phase 1

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: Hyperpolarized Xenon gas
Drug: PFP

First Posted Date: 2018-03-29

Last Posted Date: 2021-01-25

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 11

Registration Number: NCT03482960

Locations: 🇺🇸
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Modulation of Motor Cortex Excitability by TMS and tDCS (MAGS1)

Not Applicable

Completed

Conditions: Motor Activity
Motor Neuroplasticity

Interventions: Device: sham tDCS
Device: cathodal tDCS
Device: anodal tDCS

First Posted Date: 2018-03-29

Last Posted Date: 2021-03-04

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 19

Registration Number: NCT03481309

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Crowdsourcing to Promote HBV and HCV Testing in China

Not Applicable

Completed

Conditions: Hepatitis C
Hepatitis B
Hepatitis

Interventions: Other: Control
Behavioral: Crowdsourced materials

First Posted Date: 2018-03-29

Last Posted Date: 2018-06-20

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 700

Registration Number: NCT03482388

Locations: 🇨🇳
UNC Project-China, Guangzhou, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy